Thermo Fisher Scientific Inc (0R0H.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-09-27 2025-06-28 2025-03-29 2024-12-31
Revenue 11,122,000,000 10,855,000,000 10,364,000,000 11,395,000,000
Cost of Revenue 6,470,000,000 6,807,000,000 6,119,000,000 6,928,000,000
Gross Profit 4,652,000,000 4,048,000,000 4,245,000,000 4,467,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,365,000,000 1,779,000,000 2,063,000,000 1,825,000,000
Operating Expenses 2,712,000,000 2,131,000,000 2,405,000,000 2,199,000,000
Operating Income 1,943,000,000 1,917,000,000 1,840,000,000 2,268,000,000
Interest Expense 347,000,000 404,000,000 303,000,000 384,000,000
Income Before Tax 1,828,000,000 1,711,000,000 1,606,000,000 1,974,000,000
Income Tax Expense 207,000,000 92,000,000 95,000,000 150,000,000
Net Income 1,616,000,000 1,617,000,000 1,507,000,000 1,830,000,000
Per Share
EPS 4.28 4.28 3.99 4.79
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 42,879,000,000 42,857,000,000 44,915,000,000
Cost of Revenue 25,151,000,000 25,744,000,000 25,904,000,000
Gross Profit 17,728,000,000 17,113,000,000 19,011,000,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 8,676,000,000 8,445,000,000 9,015,000,000
Operating Expenses 10,066,000,000 10,254,000,000 10,486,000,000
Operating Income 7,662,000,000 6,859,000,000 8,525,000,000
Interest Expense 1,654,000,000 1,375,000,000 726,000,000
Income Before Tax 6,995,000,000 6,298,000,000 7,835,000,000
Income Tax Expense 657,000,000 284,000,000 703,000,000
Net Income 6,335,000,000 5,995,000,000 6,950,000,000
Per Share
EPS 16.58 15.53 17.73
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 4,009,000,000 8,077,000,000 8,536,000,000
Short Term Investments 1,561,000,000 -1,967,000,000 0
Net Receivables 9,626,000,000 9,664,000,000 9,427,000,000
Inventory 4,978,000,000 5,088,000,000 5,634,000,000
Total Current Assets 22,137,000,000 24,589,000,000 25,229,000,000
Property Plant Equipment 10,795,000,000 9,448,000,000 10,873,000,000
Goodwill and Intangibles 61,386,000,000 60,690,000,000 58,674,000,000
Total Assets 97,321,000,000 98,726,000,000 97,154,000,000
Liabilities
Account Payables 3,079,000,000 2,872,000,000 3,381,000,000
Short Term Debt 2,475,000,000 3,604,000,000 5,851,000,000
Total Current Liabilities 13,332,000,000 14,012,000,000 17,010,000,000
Long Term Debt 30,300,000,000 31,308,000,000 28,909,000,000
Total Liabilities 47,650,000,000 51,884,000,000 53,006,000,000
Shareholders Equity
Retained Earnings 53,102,000,000 47,364,000,000 41,910,000,000
Total Shareholders Equity 49,584,000,000 46,735,000,000 43,978,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 4,009,000,000 8,077,000,000 8,536,000,000
Short Term Investments 1,561,000,000 -1,967,000,000 0
Net Receivables 9,626,000,000 9,664,000,000 9,427,000,000
Inventory 4,978,000,000 5,088,000,000 5,634,000,000
Total Current Assets 22,137,000,000 24,589,000,000 25,229,000,000
Property Plant Equipment 10,795,000,000 9,448,000,000 10,873,000,000
Goodwill and Intangibles 61,386,000,000 60,690,000,000 58,674,000,000
Total Assets 97,321,000,000 98,726,000,000 97,154,000,000
Liabilities
Account Payables 3,079,000,000 2,872,000,000 3,381,000,000
Short Term Debt 2,475,000,000 3,604,000,000 5,851,000,000
Total Current Liabilities 13,332,000,000 14,012,000,000 17,010,000,000
Long Term Debt 30,300,000,000 31,308,000,000 28,909,000,000
Total Liabilities 47,650,000,000 51,884,000,000 53,006,000,000
Shareholders Equity
Retained Earnings 53,102,000,000 47,364,000,000 41,910,000,000
Total Shareholders Equity 49,584,000,000 46,735,000,000 43,978,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 6,338,000,000 5,995,000,000 6,950,000,000
Depreciation & Amortization 3,108,000,000 3,406,000,000 3,381,000,000
Stock Based Compensation 301,000,000 278,000,000 307,000,000
Change in Working Capital -334,000,000 -537,000,000 -1,049,000,000
Operating Cash Flow 8,667,000,000 8,406,000,000 9,154,000,000
Investing Activities
Capital Expenditure -1,400,000,000 -1,479,000,000 -2,243,000,000
Investments -1,400,000,000 -1,479,000,000 -2,243,000,000
Investing Cash Flow -5,841,000,000 -5,142,000,000 -2,159,000,000
Financing Activities
Debt Repayment -2,403,000,000 -155,000,000 -654,000,000
Common Stock Issued/Repurchased -4,000,000,000 -3,000,000,000 375,000,000
Dividends Paid -583,000,000 -523,000,000 -455,000,000
Financing Cash Flow -6,792,000,000 -3,622,000,000 -2,810,000,000
Summary
Free Cash Flow 7,267,000,000 6,927,000,000 6,911,000,000
Net Change in Cash -4,057,000,000 -440,000,000 4,046,000,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 6,338,000,000 5,995,000,000 6,950,000,000
Depreciation & Amortization 3,108,000,000 3,406,000,000 3,381,000,000
Stock Based Compensation 301,000,000 278,000,000 307,000,000
Change in Working Capital -334,000,000 -537,000,000 -1,049,000,000
Operating Cash Flow 8,667,000,000 8,406,000,000 9,154,000,000
Investing Activities
Capital Expenditure -1,400,000,000 -1,479,000,000 -2,243,000,000
Investments -1,400,000,000 -1,479,000,000 -2,243,000,000
Investing Cash Flow -5,841,000,000 -5,142,000,000 -2,159,000,000
Financing Activities
Debt Repayment -2,403,000,000 -155,000,000 -654,000,000
Common Stock Issued/Repurchased -4,000,000,000 -3,000,000,000 375,000,000
Dividends Paid -583,000,000 -523,000,000 -455,000,000
Financing Cash Flow -6,792,000,000 -3,622,000,000 -2,810,000,000
Summary
Free Cash Flow 7,267,000,000 6,927,000,000 6,911,000,000
Net Change in Cash -4,057,000,000 -440,000,000 4,046,000,000